03:44 PM EST - Endo International plc : said its pharmaceuticals division announced today the commercial availability of NATESTO™ (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism. Endo International plc
shares T.ENL are trading up $0.97 at $113.89.
